Varex Imaging Eyes 71% Upside Potential Ahead of Quarterly Earnings

Key Facts

Reflecting growing optimism in the medical technology sector, investors are closely monitoring Varex Imaging ahead of its upcoming quarterly results. According to analyst reports, the company is expected to post revenue of $214.94 million and an EPS of $0.27. This forecast is supported by a consensus 'Buy' rating from five analysts, who have set a price target of $18.00, suggesting significant upside potential.

Looking at industry peers, companies like GE HealthCare have recently demonstrated steady global demand for diagnostic imaging equipment, which bolsters the outlook for Varex as a critical component supplier. Per market data, VREX is currently trading at levels that imply a potential upside of 71.43% relative to consensus targets, reflecting analyst confidence in the company's margin recovery compared to previous quarters.

VREX shares stood at $10.2 (close June 17, 2026), having traded between a low of $10.08 and a high of $10.68 during the session per market data. Traders should watch the $10.00 support level as a key technical floor ahead of the official earnings release. With few direct sectoral catalysts in the upcoming economic calendar, the focus remains squarely on the quarterly earnings report as the primary driver for the stock.